Spiramycin I 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |

Stem definitionDrug idCAS RN
2471 24916-50-5

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • Foromacidine A
  • Spiramycin I
  • Leucomycin V
  • Molecular weight: 843.07
  • Formula: C43H74N2O14
  • CLOGP: 2.02
  • LIPINSKI: 2
  • HAC: 16
  • HDO: 4
  • TPSA: 195.38
  • ALOGS: -3.63
  • ROTB: 11

Drug dosage:

None

ADMET properties:

None

Predicted pharmacokinetic/toxicological properties (PK-AZ):

PropertyDescriptionValueUnitConfidenceSimilarity
azlogd74 LogD at pH 7.4 1.077 High 1
caco2-efflux Caco-2 efflux ratio (BA/AB) 28.840 High 1
caco2-intrinsic-papp Caco-2 intrinsic apparent permeability 1.552 10^-6 cm/s High 1
dh-clint Dog hepatocyte intrinsic clearance 8.570 uL/min/10^6 cells High 1
dppb Dog plasma protein binding (% unbound) 62.620 % High 1
fcs-ppb Fetal calf serum protein binding (% unbound) 54.190 % High 1
herg hERG pIC50 4.308 pIC50 High 1
hh-clint Human hepatocyte intrinsic clearance 2.884 uL/min/10^6 cells High 1
hlm-clint Human liver microsomal intrinsic clearance 26.977 uL/min/mg protein High 1
hppb Human plasma protein binding (% unbound) 62.080 % High 1
kinase-safety-class ACVR2B,AXL,BRAF,CAMK2D,CDK5,EIF2AK3,ERBB2,GRK2,ITK,MAP2K6,MAPK10,MAPK7,NTRK2,PDK1,PDK2,PDK4,PRKDC,TEK,TGFBR1 19
mdck-mdr1-efflux MDCK-MDR1 efflux ratio 6.950 High 1
mh-clint Mouse hepatocyte intrinsic clearance 5.970 High 1
mppb Mouse plasma protein binding (% unbound) 61.420 High 1
nih-mdck-mdr1-efflux NIH MDCK-MDR1 efflux ratio 9.954 High 1
pfas-class PFAS structural alert (1 = True, 0 = False) 0
pppb Pig plasma protein binding (% unbound) 67.280 % High 1
rh-clint Rat hepatocyte intrinsic clearance 6.918 uL/min/10^6 cells High 1
rh-fuinc Rat hepatocyte fraction unbound in incubation 78.910 % High 1
rppb Rat plasma protein binding (% unbound) 56.580 % High 1
solubility-dd Solubility at pH 7.4 in DMSO 879.023 uM High 1

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

None

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
CHEBI has role CHEBI:76969 bacterial metabolite
CHEBI has role CHEBI:33281 antimicrobial agent
CHEBI has role CHEBI:36047 antibacterial drug

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 12.8 acidic
pKa2 8.03 Basic
pKa3 7.35 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
22875-15-6 SECONDARY_CAS_RN
C0037962 UMLSCUI
CHEBI:747762 CHEBI
SPR PDB_CHEM_ID
CHEMBL6195749 ChEMBL_ID
DB06145 DRUGBANK_ID
033ECH6IFG UNII
5289394 PUBCHEM_CID
9991 RXNORM
002766 NDDF
302007 SNOMEDCT_US
387163002 SNOMEDCT_US

Pharmaceutical products:

None